Financials Integrated Diagnostics Holdings plc

Equities

IDHC

JE00BLKGSR75

Healthcare Facilities & Services

Market Closed - London S.E. 11:35:10 2024-02-23 am EST 5-day change 1st Jan Change
0.308 USD +0.98% Intraday chart for Integrated Diagnostics Holdings plc +1.15% -13.24%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 11,145 9,600 10,355 771 9,392 5,710 5,710 -
Enterprise Value (EV) 1 10,619 9,076 9,572 -712.8 9,392 5,852 5,234 4,530
P/E ratio 22.2 x 18.8 x 17.4 x 0.55 x 17.4 x 10.3 x 6.25 x 4.94 x
Yield 4.09% - 4.45% 169% - 7.79% 12.8% 16.2%
Capitalization / Revenue 5.8 x 4.31 x 3.9 x 0.15 x 2.61 x 1.39 x 1.03 x 0.88 x
EV / Revenue 5.53 x 4.08 x 3.6 x -0.14 x 2.61 x 1.42 x 0.94 x 0.7 x
EV / EBITDA 13.9 x 9.61 x 8.17 x -0.28 x 8.02 x 4.98 x 2.99 x 2.12 x
EV / FCF 47,246,296 x 18,748,476 x 12,526,030 x -298,616 x - - - -
FCF Yield 0% 0% 0% -0% - - - -
Price to Book 4.91 x 4.33 x 4.56 x 0.3 x - 2.49 x 2.02 x 1.74 x
Nbr of stocks (in thousands) 600,000 600,000 600,000 600,000 600,000 600,000 600,000 -
Reference price 2 18.57 16.00 17.26 1.285 15.65 9.517 9.517 9.517
Announcement Date 3/21/19 4/28/20 5/19/21 4/21/22 4/6/23 - - -
1EGP in Million2EGP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 1,921 2,226 2,656 5,225 3,605 4,110 5,568 6,477
EBITDA 1 762.3 944.3 1,171 2,530 1,172 1,175 1,748 2,138
EBIT 1 684.9 790.8 985.5 2,291 832.2 772.7 1,395 1,721
Operating Margin 35.65% 35.52% 37.11% 43.85% 23.08% 18.8% 25.05% 26.57%
Earnings before Tax (EBT) 717.4 758.1 969.1 2,232 853.6 - - -
Net income 1 502.1 510.9 594 1,413 541.1 575 822 982
Net margin 26.13% 22.95% 22.37% 27.04% 15.01% 13.99% 14.76% 15.16%
EPS 2 0.8375 0.8525 0.9900 2.350 0.9000 0.9271 1.524 1.928
Free Cash Flow 224.8 484.1 764.1 2,387 - - - -
FCF margin 11.7% 21.74% 28.77% 45.69% - - - -
FCF Conversion (EBITDA) 29.48% 51.26% 65.26% 94.36% - - - -
FCF Conversion (Net income) 44.76% 94.75% 128.64% 168.98% - - - -
Dividend per Share 2 0.7592 - 0.7683 2.170 - 0.7417 1.219 1.542
Announcement Date 3/21/19 4/28/20 5/19/21 4/21/22 4/6/23 - - -
1EGP in Million2EGP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S1 2019 S2 2020 S2 2022 Q1 2022 Q2 2022 Q3 2023 Q1
Net sales 1 1,061 1,166 1,706 1,180 773.6 846.3 915.3
EBITDA - 527.9 803 - - - -
EBIT 1 366.5 424.4 - 396.4 166.1 186.4 128.8
Operating Margin 34.54% 36.41% - 33.58% 21.47% 22.02% 14.07%
Earnings before Tax (EBT) - - 695.3 - - - -
Net income 223.9 287.1 415.2 296.6 124.9 -18.19 -
Net margin 21.1% 24.63% 24.34% 25.13% 16.15% -2.15% -
EPS - 0.4800 - - - - -
Dividend per Share - - - - - - -
Announcement Date 9/10/19 4/28/20 5/19/21 6/8/22 9/12/22 11/17/22 6/1/23
1EGP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - 142 - -
Net Cash position 1 526 524 784 1,484 - - 477 1,180
Leverage (Debt/EBITDA) - - - - - 0.1212 x - -
Free Cash Flow 225 484 764 2,387 - - - -
ROE (net income / shareholders' equity) 22.2% 22.8% 26.5% 58.2% - 25% 35.7% 37.9%
ROA (Net income/ Total Assets) 15.3% 14.2% 15% 27.1% - - - -
Assets 1 3,273 3,595 3,966 5,207 - - - -
Book Value Per Share 2 3.780 3.690 3.780 4.300 - 3.830 4.720 5.460
Cash Flow per Share 2 0.9300 1.160 1.470 3.780 - 1.280 2.330 3.020
Capex 1 328 213 118 253 - 238 283 308
Capex / Sales 17.07% 9.58% 4.46% 4.85% - 5.78% 5.09% 4.76%
Announcement Date 3/21/19 4/28/20 5/19/21 4/21/22 4/6/23 - - -
1EGP in Million2EGP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.517 EGP
Average target price
24.1 EGP
Spread / Average Target
+153.23%
Consensus

Quarterly revenue - Rate of surprise

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer